BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33779695)

  • 21. Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.
    Xie J; Van Damme P; Fang D; Proud CG
    J Biol Chem; 2019 May; 294(18):7169-7176. PubMed ID: 30890561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.
    Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation.
    Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG
    J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule-related proteins in neurons.
    Kenney JW; Genheden M; Moon KM; Wang X; Foster LJ; Proud CG
    J Neurochem; 2016 Jan; 136(2):276-84. PubMed ID: 26485687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts.
    Wang Y; Huang G; Wang Z; Qin H; Mo B; Wang C
    Exp Cell Res; 2018 Feb; 363(2):291-298. PubMed ID: 29355493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
    Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
    Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
    [No Abstract]   [Full Text] [Related]  

  • 28. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
    Liu R; Proud CG
    Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.
    Cheng Y; Ren X; Zhang Y; Shan Y; Huber-Keener KJ; Zhang L; Kimball SR; Harvey H; Jefferson LS; Yang JM
    Autophagy; 2013 Feb; 9(2):208-19. PubMed ID: 23182879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.
    Zhang B; Zou J; Zhang Q; Wang Z; Wang N; He S; Zhao Y; Naman CB
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.
    Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
    Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
    Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis.
    Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.
    Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D
    Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of elongation factor 2 kinase regulation in cortical neurons in response to synaptic activity.
    Kenney JW; Sorokina O; Genheden M; Sorokin A; Armstrong JD; Proud CG
    J Neurosci; 2015 Feb; 35(7):3034-47. PubMed ID: 25698741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.
    Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE
    Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival.
    Liao Y; Chu HP; Hu Z; Merkin JJ; Chen J; Liu Z; Degenhardt K; White E; Ryazanov AG
    J Biol Chem; 2016 Sep; 291(37):19545-57. PubMed ID: 27466362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.
    Smith EM; Proud CG
    EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of silencing eEF2K expression on the malignant properties of chordoma.
    Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F
    Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.
    Ju Y; Ben-David Y; Rotin D; Zacksenhaus E
    Sci Rep; 2021 Apr; 11(1):9181. PubMed ID: 33911160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.